Mitchell de Long
Corporate Officer/Principal bij AERIE PHARMACEUTICALS, INC.
Actieve functies van Mitchell de Long
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2005 | - |
Loopbaan van Mitchell de Long
Eerdere bekende functies van Mitchell de Long
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PROCTER & GAMBLE COMPANY | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Mitchell de Long
| Stanford University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Consumer Services | 2 |
| Consumer Non-Durables | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| Bedrijven in privébezit | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Beurs
- Insiders
- Mitchell de Long
- Ervaring
